Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in OncologyJohn A. Thompson, Lisa Hang, Shailender Bhatia et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 416
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19Ang Li, Rachel Rosovsky, Nicole M. Kuderer et al.|Journal of Thrombosis and Haemostasis|2021Cited by 30
Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) RegistryAng Li, Rachel Rosovsky, Nicole M. Kuderer et al.|Blood|2020Cited by 8